4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-23-014454
PRESIDENT AND CEO bought 64,516 shares at an average $1.40 ($90,484)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror PRESIDENT AND CEO | 2023-10-19 | Purchase | +48,387 | $1.40 | $67,742 | 116,387 | D |
| Bashan Dror PRESIDENT AND CEO | 2023-10-19 | Purchase | +16,129 | $1.41 | $22,742 | 132,516 | D |
| Open-market purchases · 64,516 sh · avg $1.40 · $90,484 | |||||||
Loading xslF345X05/form4-10202023_061001.xml…